Notice2026-18719
Glycine From India: Preliminary Results and Rescission, in Part, of Countervailing Duty Administrative Review; 2024
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 14, 2026
Issuing agencies
Commerce DepartmentInternational Trade Administration
Abstract
The U.S. Department of Commerce (Commerce) preliminarily determines that countervailable subsidies were provided to producers and exporters of glycine from India. In addition, Commerce is rescinding this review, in part, with respect to 27 companies. The period of review (POR) is January 1, 2024, through December 31, 2024. Interested parties are invited to comment on these preliminary results.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 176 (Monday, September 14, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 176 (Monday, September 14, 2026)]
[Notices]
[Pages 58079-58082]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-18719]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
International Trade Administration
[C-533-884]
Glycine From India: Preliminary Results and Rescission, in Part,
of Countervailing Duty Administrative Review; 2024
AGENCY: Enforcement and Compliance, International Trade Administration,
Department of Commerce.
SUMMARY: The U.S. Department of Commerce (Commerce) preliminarily
determines that countervailable subsidies were provided to producers
and exporters of glycine from India. In addition, Commerce is
rescinding this review, in part, with respect to 27 companies. The
period of review (POR) is January 1, 2024, through December 31, 2024.
Interested parties are invited to comment on these preliminary results.
DATES: Applicable September 14, 2026.
FOR FURTHER INFORMATION CONTACT: Amber Hodak, AD/CVD Operations, Office
VI, Enforcement and Compliance, International Trade Administration,
U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington,
DC 20230; telephone: (202) 482-8034.
SUPPLEMENTARY INFORMATION:
Background
On June 21, 2019, Commerce published in the Federal Register the
countervailing duty (CVD) order on glycine from India.\1\ On June 3,
2025, Commerce published the notice of the opportunity to request an
administrative review of the Order.\2\ On July 25, 2025, based on
timely requests for review, in accordance with 19 CFR 351.221(c)(1)(i),
we initiated an administrative review of the Order.\3\ On September 11,
2025, we selected Kumar Industries (Kumar) and Mulji Mehta Enterprises
(Mulji) as mandatory respondents in this review.\4\ Between August 6
and October 23, 2025, all review requests for 27 companies were timely
withdrawn.\5\
---------------------------------------------------------------------------
\1\ See Glycine from India and the People's Republic of China:
Countervailing Duty Orders, 84 FR 29173 (June 21, 2019) (Order).
\2\ See Antidumping or Countervailing Duty Order, Finding, or
Suspended Investigation; Opportunity to Request Administrative
Review and Join Annual Inquiry Service List, 90 FR 23515 (June 3,
2025).
\3\ See Initiation of Antidumping and Countervailing Duty
Administrative Reviews, 90 FR 35268 (July 25, 2025) (Initiation
Notice).
\4\ See Memorandum, ``Respondent Selection,'' dated September
11, 2025.
\5\ See Deer Park Glycine LLC's Letters, ``Partial Withdrawal of
Request for Administrative Review,'' dated August 6, 2024, and
``Partial Withdrawal of Request for Administrative Review,'' dated
October 23, 2025.
---------------------------------------------------------------------------
Due to the lapse in appropriations and Federal Government shutdown,
on November 17, 2025, Commerce tolled certain deadlines in this
administrative proceeding by 47 days.\6\ Additionally, due to a backlog
of documents that were electronically filed via Enforcement and
Compliance's Antidumping and Countervailing Duty Centralized Electronic
Service System (ACCESS) during the Federal Government shutdown, on
November 24, 2025, Commerce tolled deadlines for this administrative
proceeding by an additional 21 days.\7\ Between April 28, and August
31, 2026, Commerce extended the deadline for issuing these preliminary
results, in accordance with section 751(a)(3)(A) of the Tariff Act of
1930, as amended (the Act), until September 8, 2026.\8\
---------------------------------------------------------------------------
\6\ See Memorandum, ``Deadlines Affected by the Shutdown of the
Federal Government,'' dated November 17, 2025.
\7\ See Memorandum, ``Tolling of all Case Deadlines,'' dated
November 24, 2025.
\8\ See Memoranda, ``Extension of Deadline for Preliminary
Results of Countervailing Duty Administrative Review,'' dated April
28, 2026, and ``Second Extension of Deadline for Preliminary Results
of Countervailing Duty Administrative Review,'' dated August 31,
2026.
---------------------------------------------------------------------------
[[Page 58080]]
For a complete description of the events that followed the
initiation of this review, see the Preliminary Decision Memorandum.\9\
A list of topics included in the Preliminary Decision Memorandum is
provided as an Appendix I to this notice. The Preliminary Decision
Memorandum is a public document and is on file electronically via
ACCESS, which is available to registered users at <a href="https://access.trade.gov">https://access.trade.gov</a>. In addition, a complete version of the Preliminary
Decision Memorandum can be accessed directly at <a href="https://access.trade.gov/frnotices">https://access.trade.gov/frnotices</a>.
---------------------------------------------------------------------------
\9\ See Memorandum, ``Decision Memorandum for the Preliminary
Results of the Administrative Review of the Countervailing Duty
Order on Glycine from India; 2024,'' dated concurrently with, and
hereby adopted by, this notice (Preliminary Decision Memorandum).
---------------------------------------------------------------------------
Scope of the Order
The merchandise covered by the Order is glycine from India. For a
complete description of the scope of the Order, see the Preliminary
Decision Memorandum.\10\
---------------------------------------------------------------------------
\10\ Id.
---------------------------------------------------------------------------
Rescission of Administrative Review, in Part
Pursuant to 19 CFR 351.213(d)(1), Commerce will rescind an
administrative review, in whole or in part, if all parties that
requested the review withdraw their requests within 90 days of the date
of publication of the notice of initiation. As noted above, Commerce
received a timely filed withdrawal of review requests with respect to
the companies listed in Appendix II, and no other parties requested a
review of these companies. Therefore, we are rescinding the
administrative review, in part, with respect to these companies,
pursuant to 19 CFR 351.213(d)(1).
Pursuant to 19 CFR 351.213(d)(3), it is Commerce's practice to
rescind an administrative review of a countervailing duty order where
it concludes that there were no suspended entries of subject
merchandise during the POR.\11\ Normally, upon completion of an
administrative review, the suspended entries are liquidated at the CVD
assessment rate calculated for the POR.\12\ Therefore, for an
administrative review to be conducted, there must be a reviewable,
suspended entry that Commerce can instruct U.S. Customs and Border
Protection (CBP) to liquidate at the CVD rate calculated for the
POR.\13\ Commerce notified all interested parties of its intent to
rescind this administrative review regarding Mulji Mehta Pharma.\14\ We
received a comment from Chattem Chemicals (Chattem), claiming that
Mulji Mehta Pharma is a cross-owned affiliate of mandatory respondent
Mulji.\15\ In order to further consider this comment, we are not
rescinding the administrative review with respect to Mulji Mehta Pharma
at this time.
---------------------------------------------------------------------------
\11\ See, e.g., Certain Non-Refillable Steel Cylinders from the
People's Republic of China: Rescission of Countervailing Duty
Administrative Review; 2024, 90 FR 48043 (October 3, 2025).
\12\ See 19 CFR 351.212(b)(2).
\13\ See, e.g., Shanghai Sunbeauty Trading Co. v. United States,
380 F.Supp.3d 1328, 1337 (CIT 2019), at 12 (referring to section
751(a) of the Act, the U.S. Court of International Trade held that
``{w{time} hile the statute does not explicitly require that an
entry be suspended as a prerequisite for establishing entitlement to
a review, it does explicitly state the determined rate will be used
as the liquidation rate for the reviewed entries. This result can
only obtain if the liquidation of entries has been suspended''; see
also Certain Frozen Fish Fillets from the Socialist Republic of
Vietnam: Final Results of Antidumping Duty Administrative Review and
Final Determination of No Shipments; 2018-2019, 86 FR 36102, and
accompanying Issues and Decision Memorandum at Comment 4; and Solid
Fertilizer Grade Ammonium Nitrate from the Russian Federation:
Notice of Rescission of Antidumping Duty Administrative Review, 77
FR 65532 (October 29, 2012) (noting that ``for an administrative
review to be conducted, there must be a reviewable, suspended entry
to be liquidated at the newly calculated assessment rate'').
\14\ See Memorandum, ``Notice of Intent to Rescind Review, in
Part,'' dated August 3, 2026; see also ``Notice of Intent to Rescind
Review, In Part,'' August 20, 2026.
\15\ See Chattem's Letter, ``Chattem's Response to the
Department's Notice of Intent to Rescind Review, In Part,'' dated
August 25, 2026.
---------------------------------------------------------------------------
Methodology
Commerce is conducting this administrative review in accordance
with 751(a)(1)(A) of the Act. For each of the subsidy programs found
countervailable, Commerce preliminarily determines that there is a
subsidy, i.e., a financial contribution by an ``authority'' that gives
rise to a benefit to the recipient, and that the subsidy is
specific.\16\ For a full description of the methodology underlying our
conclusions, including our reliance, in part, on facts otherwise
available with adverse inferences pursuant to sections 776(a) and (b)
of the Act, see the Preliminary Decision Memorandum.
---------------------------------------------------------------------------
\16\ See sections 771(5)(B) and (D) of the Act regarding
financial contribution; section 771(5)(E) of the Act regarding
benefit; and section 771(5A) of the Act regarding specificity.
---------------------------------------------------------------------------
Rate for Non-Individually Examined Companies
The Act and Commerce's regulations do not address the establishment
of a rate to apply to companies not selected for individual examination
when Commerce limits its examination in an administrative review
pursuant to section 777A(e)(2) of the Act. Generally, Commerce looks to
section 705(c)(5) of the Act, which provides instructions for
calculating the all-others rate in a CVD investigation. Section
777A(e)(2) of the Act provides that ``the individual countervailable
subsidy rates determined under subparagraph (A) shall be used to
determine the all-others rate under section 705(c)(5) {of the
Act{time} .''
Under section 705(c)(5)(A)(i) of the Act, the all-others rate is
normally an amount equal to the weighted average countervailable
subsidy rates established for each of the companies individually
investigated, excluding any rates that are zero, de minimis (i.e., less
than 0.5 percent), or determined entirely on the basis of facts
available. Where the countervailable subsidy rates for each of the
individually examined companies is zero, de minimis, or based entirely
on facts available, section 705(c)(5)(A)(ii) of the Act provides that
Commerce may use ``any reasonable method to establish an all-others
rate for exporters and producers not individually investigated,
including averaging the weighted average countervailable subsidy rates
determined for the exporters and producers individually investigated.''
For these preliminary results, because the rate calculated for
Mulji is based entirely on adverse facts available, we are
preliminarily assigning to the company under review that was not
selected for individual examination (i.e., Mulji Mehta Pharma) a
countervailable subsidy rate based on the rate calculated for Kumar.
Preliminary Results of Review
As a result of this review, we preliminarily determine the
following net countervailable subsidy rates exist for the POR, January
1, 2024, through December 31, 2024: \17\
---------------------------------------------------------------------------
\17\ Commerce continues to determine that Advance Chemical
Corporation, Rexisize Rasayan Industries, Reliance Corporation, and
Rudraa International are cross-owned with Kumar Industries. See
Preliminary Decision Memorandum at 15-16; see also Glycine from
India: Final Results of Countervailing Duty Administrative Review;
2023, 91 FR 36110 (June 16, 2026).
------------------------------------------------------------------------
Subsidy rate
Company (percent ad
valorem)
------------------------------------------------------------------------
Kumar Industries........................................ 39.75
Mulji Mehta Enterprises................................. 104.92
Mulji Mehta Pharma...................................... 39.75
------------------------------------------------------------------------
Disclosure
Commerce intends to disclose its calculations and analysis
performed to interested parties for these preliminary
[[Page 58081]]
results within five days of any public announcement or, if there is no
public announcement, within five days of the date of publication of
this notice in accordance with 19 CFR 351.224(b).
Public Comment
Case briefs or other written comments may be submitted to the
Assistant Secretary for Enforcement and Compliance. Pursuant to 19 CFR
351.309(c)(1)(ii), we have modified the deadline for interested parties
to submit case briefs to Commerce to no later than 21 days after the
date of the publication of this notice.\18\ Rebuttal briefs, limited to
issues raised in the case briefs, may be filed not later than five days
after the date for filing case briefs.\19\ Interested parties who
submit case briefs or rebuttal briefs in this proceeding must submit:
(1) a table of contents listing each issue; and (2) a table of
authorities.\20 \All briefs must be filed electronically using ACCESS.
An electronically filed document must be received successfully in its
entirety in ACCESS by 5:00 p.m. Eastern Time on the established
deadline.
---------------------------------------------------------------------------
\18\ See 19 CFR 351.309.
\19\ See19 CFR 351.309(d); see also Administative Protective
Order, Service, and Other Procedures in Antidumping and
Countervailing Duty Proceedings, 88 FR 67069, 67077 (September 29,
2023) (APO and Service Procedures).
\20\ See19 CFR 351.309(c)(2) and (d)(2).
---------------------------------------------------------------------------
As provided under 19 CFR 351.309(c)(2)(iii) and (d)(2)(iii), we
request that interested parties provide at the beginning of their
briefs a public executive summary for each issue raised in their
briefs.\21\ Further, we request that interested parties limit their
executive summary of each issue to no more than 450 words, not
including citations. We intend to use the executive summaries as the
basis of the comment summaries included in the issues and decision
memorandum that will accompany the final results in this administrative
review. We request that interested parties include footnotes for
relevant citations in the public executive summary of each issue. Note
that Commerce has amended certain of its requirements pertaining to the
service of documents in 19 CFR 351.303(f).\22\
---------------------------------------------------------------------------
\21\ We use term ``issue'' here to describe an argument that
Commerce would normally address in a comment of the Issues and
Decision Memorandum.
\22\ See APO and Service Procedures.
---------------------------------------------------------------------------
Pursuant to 19 CFR 351.310(c), interested parties who wish to
request a hearing must submit a written request to the Assistant
Secretary for Enforcement and Compliance, filed electronically via
ACCESS by 5:00 p.m. Eastern Time within 30 days after the date of
publication of this notice. Requests should contain: (1) the party's
name, address, and telephone number; (2) the number of participants and
whether any participant is a foreign national; and (3) a list of issues
to be discussed. Oral presentations at the hearing will be limited to
issues raised in the briefs. If a request for a hearing is made,
Commerce will inform parties of the scheduled date for the hearing.\23\
---------------------------------------------------------------------------
\23\ See19 CFR 351.310(d).
---------------------------------------------------------------------------
Assessment Rates
Consistent with section 751(a)(1) of the Act and 19 CFR
351.212(b)(2), upon issuance of the final results, Commerce shall
determine, and CBP shall assess, countervailing duties on all
appropriate entries covered by this review.
For the companies listed in Appendix II for which the review is
being rescinded, Commerce will instruct CBP to assess countervailing
duties on all appropriate entries at a rate equal to the cash deposit
of estimated countervailing duties required at the time of entry, or
withdrawal from warehouse, for consumption in accordance with 19 CFR
351.212(c)(1)(i). Commerce intends to issue rescission instructions to
CBP for the companies listed in Appendix II no earlier than 35 days
after the date of publication of this notice in the Federal Register.
Commerce intends to issue assessment instructions to CBP regarding
Kumar, Mulji, and Mulji Mehta Pharma no earlier than 35 days after the
date of publication of the final results of this review in the Federal
Register. If a timely summons is filed at the U.S. Court of
International Trade, the assessment instructions will direct CBP not to
liquidate relevant entries until the time for parties to file a request
for a statutory injunction has expired (i.e., within 90 days of
publication).
Cash Deposit Rates
Pursuant to section 751(a)(2)(C) of the Act and 19 CFR 351.107(e),
Commerce intends to instruct CBP to collect cash deposits of estimated
countervailing duties with regard to shipments of subject merchandise
entered, or withdrawn from warehouse, for consumption on or after the
date of publication of the final results of this review as follows: (1)
the cash deposit rate for the companies listed above will be equal to
the company-specific estimated individual countervailable subsidy rates
determined in the final results of this review, except if the rate is
less than 0.50 percent and, therefore, de minimis within the meaning of
19 CFR 351.106(c)(1), in which case the cash deposit rate will be zero;
(2) if both the producer and exporter of the subject merchandise have
company-specific estimated subsidy rates assigned, and their rates
differ, then the applicable cash deposit rate will be the higher of
these two rates; (3) if either the producer or the exporter, but not
both, of the subject merchandise has a company-specific estimated
subsidy rate assigned, the applicable cash deposit rate will be that
company's company-specific rate; and (4) the cash deposit rate for all
other producers and exporters will be continue to be 5.01 percent, the
all-others subsidy rate established in the investigation.24 These cash
deposit instructions, when imposed, shall remain in effect until
further notice.
Final Results
Unless the deadline is extended, Commerce intends to issue the
final results of this administrative review, which will include the
results of Commerce's analysis of the issues raised in the case briefs,
within 120 days of these preliminary results in the Federal Register,
pursuant to section 751(a)(3)(A) of the Act and 19 CFR 351.213(h)(1).
Notification to Interested Parties
We are issuing and publishing these preliminary results in
accordance with sections 751(a)(1) and 777(i)(1) of the Act, and 19 CFR
351.221(b)(4).
Dated: September 8, 2026.
Christopher Abbott,
Deputy Assistant Secretary for Policy and Negotiations, performing the
non-exclusive functions and duties of the Assistant Secretary for
Enforcement and Compliance.
Appendix I
List of Topics Discussed in the Preliminary Decision Memorandum
I. Summary
II. Background
III. Scope of the Order
IV. Use of Facts Otherwise Available and Application of Adverse
Inferences
V. Subsidies Valuation
VI. Benchmarks and Interest Rates
VII. Analysis of Programs
VIII. Recommendation
Appendix II
Companies for Which Commerce Is Rescinding the Administrative Review
1. Aditya Chemicals
2. Adwith Nutrichem Private Limited
3. Avid Organics Private Limited
4. Bajaj Healthcare Limited
5. Elementis Specialties India Private Limited
6. Euroasia Trans Continental
7. Euroasias Organics Private Limited
8. Galaxy Surfactants Limited
9. Glisten Biotech
10. Grauer & Weil (India) Limited
11. Gujarat Ambuja Export Limited
12. Gulbrandsen Technologies (India) Private Limited
[[Page 58082]]
13. Indiana Chem Port
14. Kronox Lab Sciences Private Limited
15. Mass Dye Chem. Private Limited
16. Medilane Healthcare Private Limited
17. Meteoric Biopharmaceuticals Private Limited
18. Mumbai Merchant
19. Nature Bio
20. Priya Chemicals
21. Promois International Limited
22. Paras Intermediates Private Limited
23. Shari Pharmachem Private Limited
24. Strava Healthcare Private Limited
25. Tarkesh Trading Co.
26. Valaji Pharma Chem
27. Venus International Exports Private Limited
[FR Doc. 2026-18719 Filed 9-11-26; 8:45 am]
BILLING CODE 3510-DS-P
</pre></body>
</html>Indexed from Federal Register on September 14, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.